Drupal.behaviors.print = function(context) {window.print();window.close();}>
Myriad Genetics to Acquire Rules-Based Medicine for $80M
April 28, 2011
Myriad Genetics to Acquire Rules-Based Medicine for $80M
The acquisition is expected to help build Myriad's companion diagnostics franchise.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Myriad Completes $80M Acquisition of Rules-Based Medicine
June 1, 2011 / GenomeWeb Daily News
Myriad, PharmaMar Enter CDx Agreement for HRD Test
March 27, 2013 / GenomeWeb Daily News
EKF Establishes MDx Subsidiary, Buys Cancer Dx Company 360 Genomics
March 4, 2013 / GenomeWeb Daily News
Myriad RBM, Sanofi Partner on Biomarkers for Diabetes
December 11, 2012 / GenomeWeb Daily News
Agilent Buying Cancer Diagnostics Company Dako for $2.2B
May 17, 2012 / GenomeWeb Daily News